Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genelux (GNLX) Shares Issued (2023 - 2025)

Genelux has reported Shares Issued over the past 3 years, most recently at $9.5 million for Q4 2025.

  • Quarterly results put Shares Issued at $9.5 million for Q4 2025, up 63493.33% from a year ago — trailing twelve months through Dec 2025 was $9.6 million (up 1259.03% YoY), and the annual figure for FY2025 was $9.6 million, up 7542.4%.
  • Shares Issued for Q4 2025 was $9.5 million at Genelux, up from $15000.0 in the prior quarter.
  • Over the last five years, Shares Issued for GNLX hit a ceiling of $14.5 million in Q1 2023 and a floor of -$11.5 million in Q4 2023.
  • Median Shares Issued over the past 3 years was $351500.0 (2024), compared with a mean of $2.2 million.
  • Biggest five-year swings in Shares Issued: crashed 95.26% in 2024 and later skyrocketed 63493.33% in 2025.
  • Genelux's Shares Issued stood at -$11.5 million in 2023, then skyrocketed by 100.13% to $15000.0 in 2024, then skyrocketed by 63493.33% to $9.5 million in 2025.
  • The last three reported values for Shares Issued were $9.5 million (Q4 2025), $15000.0 (Q4 2024), and $688000.0 (Q1 2024) per Business Quant data.